Pure Global

Rapid Dipstick Test for Detection of phIGFBP-1 in Cervical Secretion as Pre-Term Birth Risk Factor - India CDSCO Medical Device Registration

Rapid Dipstick Test for Detection of phIGFBP-1 in Cervical Secretion as Pre-Term Birth Risk Factor is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000208_dbd45e732a89c1580905f65627f4ce0f_df4e4bbced3e4acc3753501d48b2ac86. This device is marketed under the brand name EzDx Actim Partus . The license holder is ADVY CHEMICAL PVT. LTD., and it is classified as Device Class Class B. The approving authority is Kokan Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Rapid Dipstick Test for Detection of phIGFBP-1 in Cervical Secretion as Pre-Term Birth Risk Factor
UID: MFG/MD/2020/000208_dbd45e732a89c1580905f65627f4ce0f_df4e4bbced3e4acc3753501d48b2ac86

Brand Name

EzDx Actim Partus

Device Class

Class B

Approving Authority

Kokan Division

Product Information

Actim Partus is a visually interpreted, qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (EzDx Actim Partus ) in cervical secretions during pregnancy. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact. A negative test result is a clear indication that the patient will not deliver within 7-14 days

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing